Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neurocrine Biosciences Inc (NASDAQ:NBIX)

59.03
Delayed Data
As of Oct 20
 +0.07 / +0.12%
Today’s Change
37.35
Today|||52-Week Range
63.77
+52.53%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Obrien Christopher Flint
Chief Medical Officer
Sale5/18/2017105,634$53.32$5.6M+10.17%
Obrien Christopher Flint
Chief Medical Officer
Sale9/05/201752,817$57.50$3.0M+1.72%
Obrien Christopher Flint
Chief Medical Officer
Sale11/15/201625,000$52.84$1.3M+11.52%
Gano Kyle
Chief Business Development Officer
Sale9/06/201720,393$60.00$1.2M+0.67%
Gorman Kevin Charles
Chief Executive Officer
Sale5/02/201721,739$53.23$1.2M+9.66%
Bozigian Haig P
Chief Development Officer
Sale8/04/201720,000$50.00$1.0M+10.34%
Gorman Kevin Charles
Chief Executive Officer
Sale4/12/201719,290$50.41$972.4K+13.96%
Bozigian Haig P
Chief Development Officer
Sale9/06/201715,000$60.00$900.0K+0.67%
Grigoriadis Dimitri E
Chief Research Officer
Sale8/09/201715,354$55.00$844.5K+7.76%
Gano Kyle
Chief Business Development Officer
Sale5/01/201715,000$54.00$810.0K+8.01%
Page of 10